At LEO Pharma, we interact with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) to provide or obtain scientific or educational knowledge or to support our medical research.
We are committed to uphold high ethical standards and to ensure compliance when interacting with HCPs and HCOs and we want to ensure that all interactions are conducted in line with the LEO Pharma value of integrity - in a transparent way.
Interactions with HCPs and HCOs are conducted in accordance with the LEO Code of Conduct, applicable LEO internal guidelines as well as applicable laws, ethical codes and regulations.
In addition, LEO Pharma is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and we are committed to comply with the EFPIA codes, including the EFPIA Disclosure Code. This means that LEO Pharma will make available to the public any payments and expenses (transfers of value) made on behalf of LEO Pharma to HCPs and HCOs with principal practice address in an EFPIA country in accordance with the EFPIA requirements.
The transfers of value will be disclosed locally in accordance with any additional country-specific requirements. However, for LEO entities without a local company website and countries without representation by LEO Pharma, the related local disclosure documents are listed here.
EFPIA Global Methodological Note
We have prepared a Global Methodological Note on the EFPIA HCP/HCO disclosures. The Global Methodological Note describes how LEO Pharma - on a global level - ensures transparency with regards to the transfers of value that we make to HCPs and HCOs in the EFPIA countries. The Global Methodological Note is available at the bottom of this page. In each EFPIA country where LEO is operating, a local methodological note is available on the country-specific website, as per local requirements.
EFPIA Disclosure Code Self-Certification Scheme
As a member of EFPIA, we have signed the EFPIA Disclosure Code Self-Certification Scheme which confirms that the disclosures of transfers of value to HCPs and HCOs made on behalf of LEO Pharma in the previous year have been reported in compliance with these disclosure requirements. The signed Self-Certification Scheme is available at the bottom of this page.